You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 10, 2025

Drug Price Trends for NDC 23155-0875


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 23155-0875

Drug NameNDCPrice/Unit ($)UnitDate
LETROZOLE 2.5 MG TABLET 23155-0875-03 0.13983 EACH 2025-03-19
LETROZOLE 2.5 MG TABLET 23155-0875-09 0.13983 EACH 2025-03-19
LETROZOLE 2.5 MG TABLET 23155-0875-10 0.13983 EACH 2025-03-19
LETROZOLE 2.5 MG TABLET 23155-0875-03 0.13700 EACH 2025-02-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 23155-0875

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Drug NDC: 23155-0875

Understanding the NDC Directory

To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand the role of the NDC Directory. The FDA's National Drug Code Directory is a comprehensive resource that contains information about finished drug products, unfinished drugs, and compounded drug products. Each drug is identified by a unique three-segment NDC number, which serves as the FDA’s identifier for drugs[1].

Identifying the Drug

The NDC number 23155-0875 is not explicitly mentioned in the provided sources, but we can infer how to analyze such a drug using the NDC Directory.

  • Drug Identification: The NDC Directory allows searches by proprietary name, application number, labeler name, active ingredient, or the NDC number itself. For example, if we were to search for a drug like Ondansetron (NDC: 23155-0548), the directory would provide detailed information including the product type name, non-proprietary name, dosage form, route of administration, marketing dates, and package details[1][5].

Market Analysis

Therapy Area and Market Trends

To conduct a market analysis, one must consider the therapy area and current market trends.

  • Therapy Area: Identify the therapeutic category of the drug. For instance, if the drug is used in oncology, it would be part of a highly competitive and rapidly evolving market. The non-small cell lung cancer (NSCLC) market, for example, is expected to grow significantly due to increasing incidence rates and the adoption of targeted therapies[4].
  • Market Trends: Pharmaceutical companies are increasingly focusing on novel modalities and mechanisms of action, targeting therapy areas with high unmet needs. This shift can impact the market dynamics and pricing strategies for drugs in various therapeutic categories[3].

Competitive Landscape

  • Competitors: Analyze the competitive landscape by identifying other drugs in the same therapeutic category. For NSCLC, drugs like Tagrisso (osimertinib), Avastin (bevacizumab), and Cyramza (ramucirumab) are key players with significant market shares and growth projections[4].
  • Generic and Biosimilar Impact: The entry of generics and biosimilars can significantly impact the pricing and market share of branded drugs. For example, the patent expiration of blockbuster drugs like Tarceva and Alimta has led to a decline in their sales and an increase in generic sales[4].

Price Projections

Current Pricing

  • List Prices: Obtain the current list prices of the drug from the NDC Directory or other reliable sources. This information can help in understanding the baseline pricing.
  • Discounts and Rebates: Consider the discounts and rebates that may be applied, which can affect the net price of the drug.

Future Pricing Trends

  • Market Growth: If the drug is in a growing market, such as NSCLC, the prices might be influenced by the increasing demand and the introduction of new therapies. Targeted therapies in NSCLC are expected to drive significant growth, with Tagrisso projected to achieve blockbuster status by 2025[4].
  • Regulatory and Legislative Changes: Changes in regulations or legislation can impact pricing. For instance, proposed legislation affecting domestic manufacturing and supply chain diversification could influence drug prices[3].

Economic and Geopolitical Factors

  • Supply Chain Resilience: The pharmaceutical industry is focusing on optimizing supply chains for sustainability and resilience. This could affect production costs and subsequently influence pricing strategies[3].
  • Global Economic Dynamics: Economic changes and geopolitical threats can impact the pricing of drugs, especially if they affect the supply chain or manufacturing costs.

Example Analysis

While the specific drug with NDC 23155-0875 is not detailed, here is an example of how one might analyze a similar drug:

  • If the drug is an oncology medication, its market would be influenced by the trends in the NSCLC market. For instance, if it is a targeted therapy, it could see significant growth similar to Tagrisso, with a projected CAGR of 56.6%[4].
  • The competitive landscape would include other targeted therapies and the impact of generics and biosimilars. For example, if the drug faces patent expiration, its sales could decline similar to Tarceva and Alimta[4].
  • Price projections would consider the current list price, discounts, and rebates, as well as future market growth and regulatory changes.

Key Takeaways

  • Market Analysis: Understanding the therapy area, competitive landscape, and market trends is crucial for analyzing the market for a specific drug.
  • Price Projections: Future pricing trends are influenced by market growth, regulatory changes, and economic and geopolitical factors.
  • NDC Directory: The FDA's NDC Directory is a vital resource for identifying and gathering detailed information about drugs.

FAQs

  1. What is the NDC Directory?

    • The NDC Directory is a comprehensive resource by the FDA that contains information about finished drug products, unfinished drugs, and compounded drug products, identified by unique NDC numbers[1].
  2. How do I find information about a specific drug using the NDC Directory?

    • You can search the NDC Directory using the proprietary name, application number, labeler name, active ingredient, or the NDC number itself[1][5].
  3. What factors influence the pricing of pharmaceutical drugs?

    • Pricing is influenced by market growth, competitive landscape, regulatory changes, economic and geopolitical factors, and the impact of generics and biosimilars[3][4].
  4. How does the introduction of generics and biosimilars affect drug prices?

    • The introduction of generics and biosimilars can significantly reduce the sales and prices of branded drugs, as seen in the NSCLC market with drugs like Tarceva and Alimta[4].
  5. What role does AI and data play in pharmaceutical market trends?

    • AI and data are increasingly used to foster innovation, reduce drug development costs and timelines, and optimize supply chains, which can impact market trends and pricing strategies[3].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. 23155-0548 Ondansetron - CanMED: NDC - SEER Cancer
  3. Exploring 2025 pharma industry trends, outlook and strategies - ZS
  4. NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - GlobalData
  5. NDC Directory (March 2015) - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.